| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.03 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.26 | 0.04 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |